From the perspective of modern pharmacology, ginseng is rich in ginsenoside Rg3 (CS-Rg3) that can effectively inhibit the main pathways for the survival of cancer cells, namely, the activity of PI3K and AKT, and then induce HEC-1-B apoptosis. The gene discussed is AKT1; the disease is cancer.